News

GlaxoSmithKline has announced the purchase of 306,478 of its own ordinary shares as part of its ongoing buyback programme. This transaction, executed through Merrill Lynch International, is part of a ...
Arab Finance: GlaxoSmithKline Egypt (GSK–Egypt) logged consolidated net profits for controlling interest of EGP 65.060 ...
GlaxoSmithKline ( ($GB:GSK) ) just unveiled an update. GSK plc announced the acquisition of ordinary shares by several key executives under the ...
GSK Egypt posted non-consolidated net profits after tax of EGP 71.33 million in H1-25, an annual drop from EGP 99.54 million. Meanwhile, the EPS declined to EGP 0.85 from EGP 1.19. In April-June 2025, ...
The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.
Goldilocks inflation data fuels rally from Wall Street to Asia ​Stock markets worldwide hit fresh record highs on Wednesday, ...
In a report released today, Justin Smith from Bernstein maintained a Buy rating on GlaxoSmithKline, with a price target of £21.70. The company’s shares closed today at p1,373.00. Take advantage of ...
The number of significant shareholder protests has more than doubled so far this year compared with a year ago, with 11 FTSE ...
The market for IBAT inhibitors is projected to experience significant growth in the near future, fueled by the rising incidence of genetic disorders, a strong pipeline of clinical trials, and ...
US markets dip on Monday ahead of Tuesday's CPI print ​On Monday, US markets pulled back slightly amid growing inflation ...
Detailed price information for Ideaya Biosciences Inc (IDYA-Q) from The Globe and Mail including charting and trades.
Some FTSE 100 CEOs may have their pay climb even higher. For example, Emma Walmsley, boss at pharmaceutical giant ...